Michael David Green, MD, MPH
- Professor of Pediatrics, Surgery, and Clinical and Translational Science
- Medical Director, Infection Prevention and Antimicrobial Stewardship, UPMC Children's Hospital of Pittsburgh
Michael Green, MD, MPH is Professor of Pediatrics, Surgery, and Clinical and Translational Science at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Illinois in Chicago and his master’s degree from the University of Pittsburgh. He completed a pediatric residency and a fellowship in pediatric infectious diseases at Children’s Hospital of Pittsburgh.
Throughout his career, Green’s clinical and research interest have focused on the prevention and treatment of infections in immunocompromised children with a particular interest in the care of children undergoing solid organ transplantation. His involvement in this and other at-risk pediatric populations has required him to address issues of the expanding problem of antimicrobial resistance and to provide care to children with multidrug and pan-resistant bacterial pathogens prompting an important focus of career on antimicrobial stewardship. Green has served as the medical director of the Antimicrobial Stewardship Program at UPMC Children’s Hospital of Pittsburgh since its inception approximately nine years ago and was the recipient of the 2017 Pennsylvania Department of Health Antimicrobial Stewardship Ambassador Award. Green has also served as the Medical Director of Infection Prevention and Chairman of the UPMC Children’s Hospital of Pittsburgh Infection Control Committee since 1999. In this role he has worked to establish working groups of “champions” amongst key stakeholder groups to optimize infection prevention strategies and outcomes within the hospital.
Among his professional affiliations, Green is a member of the Pediatric Infectious Disease Society, the American Pediatric Society, the Infectious Diseases Society of America, the International Pediatric Transplant Association, and the American Society of Transplantation (AST). Green has published more than 135 peer-reviewed articles, has been invited to author over 45 publications, and has written more than 70 review articles or textbook chapters. He serves as an Associate Editor for both Pediatric Transplantation and the Journal of the Pediatric Infectious Disease Society. He was co-editor of the First Edition of the Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation published by the American Society of Transplantation and is currently Editor-in-chief of the upcoming fourth edition which is in development at this time. He currently serves on the Pediatric Infectious Diseases Sub-board of the American Board of Pediatrics and is a member of the FDA Antimicrobial Advisory Committee. He has participated in numerous Consensus Conference and Guideline working groups relating to the field of transplant infectious diseases and previously served as the chair for the OPTN/UNOS ad hoc Disease Transmission Advisory Committee.
An active teacher and clinical researcher, Green has been invited to present his work at national and international conferences, and has consistently received grant funding for his work since 1987.
Professional and Scientific Society Memberships
- American Academy of Pediatrics, Junior Fellow, 1985
- American Society of Microbiology, 1986
- Infectious Disease Society of America, Associate Member, 1987
- Pediatric Infectious Disease Society, 1988
- Infectious Disease Society of America, Member, 1993
- Society for Pediatric Research, 1994
- American Society of Transplantation, 1997
- Infectious Disease Society of America, Fellow, 1997
- International Pediatric Transplantation Association, 2000
- American Pediatric Society, 2004
- American Society of Transplantation, Fellow, 2015
Education & Training
- BS, Biochemistry, University of Illinois, 1979
- MD, University of Illinois College of Medicine, 1983
- Residency in Pediatrics, UPMC Children's Hospital of Pittsburgh, 1986-1989
- Fellowship in Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, 1986-1989
- MPH, University of Pittsburgh Graduate School of Public Health, 1989
Danziger-Isakov L; Englund J; Green M; Posfay-Barbe KM; Zerr DM. Cytomegalovirus in Pediatric Hematopoietic Stem Cell Transplantation: A Case-Based Panel Discussion of Current Challenges. Pediatric Infect Dis Soc. 7(suppl_2):S72-S74, 2018 Dec 26.
Alcamo AM; Alessi LJ; Vehovic SN; Bansal N; Bond GJ; Carcillo JA; Green M; Michaels MG; Aneja RK. Severe Sepsis in Pediatric Liver Transplant Patients: The Emergence of Multidrug-Resistant Organisms. Pediatr Crit Care Med. 20(7):e326-e332, 2019 Jul.
L'Huillier AG; Green M; Danziger-Isakov L; Chaudhuri A; HOcker B; Van der Linden D; Goddard L; Ardura MI; Stephens D; Verma A; Evans HM; McCulloch M; Michaels MG; Posfay-Barbe KM; Allen UD. Infections among pediatric transplant candidates: An approach to decision-making. Pediatric Transplantation. 23(3):e13375, 2019 05.
Walker LW, Montoya L, Chochua S, Beall B, Green M. Increase in Invasive Group A Streptococcal Disease and Emergence of Mucoid Strains in a Pediatric Population: February-June 2017. Open Forum Infectious Diseases. 6(7):ofz275, 2019 Jul DOI: 10.1093/ofid/ofz275
Suresh S, Upton J. Green M, Pham‐Huy A, Posfay‐Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger‐Isakov L, Dipchand AI, Hébert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon JM, Tapiero B, Verma A, Walter JE, Allen UD. Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018. Pediatric Transplantation. 23(7):e13571, 2019 Nov
Green M; Blumberg EA; Danziger-Isakov L; Huprikar S; Kotton CN; Kumar D. Foreword: 4th edition of the American Society of Transplantation Infectious Diseases Guidelines. Clin Transplant. e13642, 2019 Jun 19. https://dx.doi.org/10.1111/ctr.13642
Haidar G; Green M; American Society of Transplantation Infectious Diseases Community of Practice. Intra-abdominal infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. e13595, 2019 May 18. https://dx.doi.org/10.1111/ctr.13595
Paulsen G, Michaels M, Danziger-Isakov L, Dipchand AI, Green M, McCulloch M. Variability of Pneumocystis jirovecii Prophylaxis Use Among Pediatric Solid Organ Transplant Providers. Pediatric Transplantation. e13609, 2019 Nov 12.
Ashokkumar C, Soltys K, Green M, Mazariegos G, Michaels MG, Reyes M, Higgs BW, Spishock B, Zaccagnini M, Sethi P, Rzempoluch A, Kepler A, Kachmar P, Remaley L, Winnier J, Jones K, Moir K, Fazzolare T, Jenkins K, Hartle T, Falik R, Ningappa M, Bond G, Ganoza A, Sun Q, Sindhi R. CD154-expressing CMV-specific T-cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation. Pediatric Transplantation. e13601, 2019 Oct 27.
Alcamo AM, Wolf MS, Alessi LJ, Chong HJ, Green M, Williams JV, Simon, DW. Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis. Pediatrics. 145(1), 2020 Jan
Northwestern University, A Phase II, Multi Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recients > 6 Years of Age, 2016-2020, $49,411.
Children's Hospital of Philadelphia, A Multi-Center Prospective Study of Human Adenovirus Infection and Disease in Pediatric Human Stem Cell Transplant Recipients, 2016-2021, $56,167.